α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes

Citations Over TimeTop 1% of 2018 papers

Abstract

Many patients with type 1 diabetes (T1D) have residual β cells producing small amounts of C-peptide long after disease onset but develop an inadequate glucagon response to hypoglycemia following T1D diagnosis. The features of these residual β cells and α cells in the islet endocrine compartment are largely unknown, due to the difficulty of comprehensive investigation. By studying the T1D pancreas and isolated islets, we show that remnant β cells appeared to maintain several aspects of regulated insulin secretion. However, the function of T1D α cells was markedly reduced, and these cells had alterations in transcription factors constituting α and β cell identity. In the native pancreas and after placing the T1D islets into a non-autoimmune, normoglycemic in vivo environment, there was no evidence of α-to-β cell conversion. These results suggest an explanation for the disordered T1D counterregulatory glucagon response to hypoglycemia.

Related Papers

• → New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions(2021)27 cited
• → Normal Relationship of β- and Non–β-Cells Not Needed for Successful Islet Transplantation(2007)55 cited
• → Glucagon: Structure-Function Relationships Investigated by Sequence Deletions(1981)41 cited
• → ABNORMAL GLUCAGON RESPONSE IN CHILDREN WITH DUMPING SYNDROME(1997)1 cited
• → Biological Activities of Deshistidine-glucagon(1971)